Chemical activators of Nim1 function by modulating intracellular signaling pathways that lead to the protein's activation. Forskolin is a well-known activator of adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). The increase in cAMP levels results in the activation of protein kinase A (PKA), a key kinase that can phosphorylate and thereby activate Nim1. Similarly, 8-Bromo-cAMP, a cAMP analog, can permeate cell membranes and directly activate PKA, which in turn phosphorylates and activates Nim1. Isoproterenol, a beta-adrenergic agonist, enhances cAMP production by stimulating adenylate cyclase via the beta-adrenergic receptor, leading to PKA activation and subsequent Nim1 phosphorylation and activation.
Rolipram and IBMX act as phosphodiesterase inhibitors, preventing the breakdown of cAMP and thereby sustaining an elevated level of this messenger molecule within the cell. This persistence of cAMP prolongs the activation state of PKA, which then consistently activates Nim1. Prostaglandin E1 (PGE1) and Epinephrine, through interaction with their respective receptors, also raise cAMP levels. PGE1 binds to its receptor leading to adenylate cyclase activation, whereas epinephrine interacts with beta-adrenergic receptors achieving the same effect. Both routes culminate in the PKA-mediated activation of Nim1. Glucagon, by binding to its specific receptor, and Terbutaline and Salbutamol, by activating beta2-adrenergic receptors, all enhance cAMP levels, enabling PKA activation and in turn, the activation of Nim1.
Dibutyryl-cAMP, another cell-permeable analog of cAMP, directly activates PKA, bypassing the receptor-mediated steps and leading to Nim1 activation. Lastly, Anagrelide inhibits phosphodiesterase III, resulting in increased cAMP and PKA activation. The common thread among these chemical activators is their ability to raise intracellular cAMP levels, either by promoting its production, mimicking its action, or inhibiting its degradation, which leads to the activation of PKA and the subsequent activation of Nim1 through phosphorylation. This cascade of events highlights the pivotal role of cAMP and PKA in the regulation and activation of Nim1, underscoring the importance of these signaling molecules in cellular processes.
Siehe auch...
Produkt | CAS # | Katalog # | Menge | Preis | Referenzen | Bewertung |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin erhöht direkt den cAMP-Spiegel, von dem bekannt ist, dass er Nim1 aktiviert, indem er die Aktivierung der Proteinkinase A (PKA) fördert, die Nim1 phosphorylieren und damit aktivieren kann. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
8-Bromo-cAMP ist ein zellpermeables cAMP-Analogon, das PKA aktiviert, was zur Phosphorylierung und Aktivierung von Nim1 führt. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram hemmt die Phosphodiesterase-4 und verhindert so den Abbau von cAMP, was zur PKA-Aktivierung und zur anschließenden Aktivierung von Nim1 beiträgt. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX ist ein nicht-selektiver Phosphodiesterase-Inhibitor, der den Abbau von cAMP verhindert, die PKA-Aktivität erhöht und dadurch möglicherweise zur Aktivierung von Nim1 führt. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $30.00 $142.00 | 16 | |
Prostaglandin E1 (PGE1) erhöht den cAMP-Spiegel, wodurch PKA aktiviert wird, das wiederum Nim1 phosphorylieren und aktivieren kann. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrin interagiert mit beta-adrenergen Rezeptoren, wodurch der cAMP-Spiegel steigt und PKA aktiviert wird, was wiederum Nim1 aktivieren kann. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $90.00 $371.00 | 2 | |
Terbutalin, ein beta2-adrenerger Rezeptor-Agonist, erhöht den cAMP-Spiegel, wodurch PKA aktiviert wird, was zur Aktivierung von Nim1 führen kann. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $92.00 $138.00 | ||
Salbutamol aktiviert beta2-adrenerge Rezeptoren, was zu einem Anstieg von cAMP und einer Aktivierung von PKA führt, das Nim1 aktivieren kann. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP ist ein weiteres zelldurchlässiges cAMP-Analogon, das PKA aktiviert, was zu einer möglichen Aktivierung von Nim1 führt. |